The Dutch LATER physical outcomes set for self-reported data in survivors of childhood cancer

被引:14
|
作者
Streefkerk, Nina [1 ,2 ]
Tissing, Wim J. E. [2 ,3 ]
van der van der Loo, Margriet [4 ]
Feijen, Elizabeth A. M. [1 ,2 ]
van Dulmen-den Broeder, Eline [2 ,5 ]
Loonen, Jacqueline J. [6 ]
van der Pal, Helena J. H. [2 ]
Ronckers, Cecile M. [1 ,2 ]
van Santen, Hanneke M. [2 ,7 ]
van den Berg, Marleen H. [5 ]
Mulder, Renee L. [2 ]
Korevaar, Joke C. [8 ]
Kremer, Leontine C. M. [1 ,2 ]
机构
[1] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Oncol, Amsterdam UMC, Amsterdam, Netherlands
[2] Princess Maxima Ctr Pediat Oncol, Heidelberglaan 25, Utrecht 3584 CS, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol Hematol, Groningen, Netherlands
[4] Dutch Childhood Oncol Grp, Utrecht, Netherlands
[5] Vrije Univ Amsterdam, Amsterdam UMC, Dept Pediat Oncol Hematol, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Dept Hematol, Med Ctr, Nijmegen, Netherlands
[7] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Endocrinol, Utrecht, Netherlands
[8] Netherlands Inst Hlth Serv Res, Utrecht, Netherlands
关键词
Childhood cancer survivors; Long-term morbidity; Outcome assessment; Outcome definition; LONG-TERM SURVIVORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEALTH-RELATED OUTCOMES; ACUTE MYELOID-LEUKEMIA; ADULT SURVIVORS; FOLLOW-UP; EWING SARCOMA; BRAIN-TUMORS; CHILDREN; RISK;
D O I
10.1007/s11764-020-00880-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purposes Studies investigating self-reported long-term morbidity in childhood cancer survivors (CCS) are using heterogeneous outcome definitions, which compromises comparability and include (un)treated asymptomatic and symptomatic outcomes. We generated a Dutch LATER core set of clinically relevant physical outcomes, based on self-reported data. Clinically relevant outcomes were defined as outcomes associated with clinical symptoms or requiring medical treatment. Methods First, we generated a draft outcome set based on existing questionnaires embedded in the Childhood Cancer Survivor Study, British Childhood Cancer Survivor Study, and Dutch LATER study. We added specific outcomes reported by survivors in the Dutch LATER questionnaire. Second, we selected a list of clinical relevant outcomes by agreement among a Dutch LATER experts team. Third, we compared the proposed clinically relevant outcomes to the severity grading of the Common Terminology Criteria for Adverse Events (CTCAE). Results A core set of 74 self-reported long-term clinically relevant physical morbidity outcomes was established. Comparison to the CTCAE showed that 36% of these clinically relevant outcomes were missing in the CTCAE. Implications for Cancer Survivors This proposed core outcome set of clinical relevant outcomes for self-reported data will be used to investigate the self-reported morbidity in the Dutch LATER study. Furthermore, this Dutch LATER outcome set can be used as a starting point for international harmonization for long-term outcomes in survivors of childhood cancer.
引用
收藏
页码:666 / 676
页数:11
相关论文
共 50 条
  • [21] Concordance of Child Self-Reported and Parent Proxy-Reported Posttraumatic Growth in Childhood Cancer Survivors
    Koutna, Veronika
    Blatny, Marek
    Jelinek, Martin
    CANCERS, 2021, 13 (16)
  • [22] The effects of response bias on self-reported quality of life among childhood cancer survivors
    Tara E. O’Leary
    Lisa Diller
    Christopher J. Recklitis
    Quality of Life Research, 2007, 16 : 1211 - 1220
  • [23] The Effect of Response Bias on Self-Reported Quality of Life in Adult Survivors of Childhood Cancer
    Recklitis, C.
    PSYCHO-ONCOLOGY, 2012, 21 : 115 - 115
  • [24] Subclinical late cardiac toxicity in childhood cancer survivors - Impact on self-reported health
    Cox, Cheryl L.
    Rai, Shesh N.
    Rosenthal, David
    Phipps, Sean
    Hudson, Melissa M.
    CANCER, 2008, 112 (08) : 1835 - 1844
  • [25] The effects of response bias on self-reported quality of life among childhood cancer survivors
    O'Leary, TE
    Recklitis, CJ
    PSYCHO-ONCOLOGY, 2004, 13 (01) : S23 - S24
  • [26] Self-reported worries among long-term survivors of childhood cancer and their peers
    Weigers, ME
    Chesler, MA
    Zebrack, BJ
    Goldman, S
    JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 1998, 16 (02) : 1 - 23
  • [27] The effects of response bias on self-reported quality of life among childhood cancer survivors
    O'Leary, Tara E.
    Diller, Lisa
    Recklitis, Christopher J.
    QUALITY OF LIFE RESEARCH, 2007, 16 (07) : 1211 - 1220
  • [28] Comparison of self-reported late effects with medical records among survivors of childhood cancer
    Taylor, Naomi
    Absolom, Kate
    Michel, Gisela
    Urquhart, Tanya
    Gerrard, Mary
    Jenkins, Anna
    Lee, Vicki
    Vora, Ajay
    Eiser, Christine
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (06) : 1069 - 1078
  • [29] Validity of self-reported data on pregnancies for childhood cancer survivors: a comparison with data from a nationwide population-based registry
    Overbeek, A.
    van den Berg, M. H.
    Hukkelhoven, C. W. P. M.
    Kremer, L. C.
    van den Heuvel-Eibrink, M. M.
    Tissing, W. J. E.
    Loonen, J. J.
    Versluys, A. B.
    Bresters, D.
    Kaspers, G. J. L.
    Lambalk, C. B.
    van Leeuwen, F. E.
    van Dulmen-den Broeder, E.
    HUMAN REPRODUCTION, 2013, 28 (03) : 819 - 827
  • [30] Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study
    Feijen, Elizabeth A. M.
    Teepen, Jop C.
    van Dulmen-den Broeder, Eline
    van den Heuvel-Eibrink, Marry M.
    van der Heiden-van der Loo, Margriet
    van der Pal, Helena J. H.
    de Vries, Andrica C. H.
    Louwerens, Marloes
    Bresters, Dorine
    Versluys, Birgitta
    de Ridder, Hanneke
    Veening, Margreet
    van Leeuwen, Flora E.
    Grootenhuis, Martha
    Maurice-Stam, Heleen
    van Santen, Hanneke M.
    Neggers, Sebastian J. C. M. M.
    Pluijm, Saskia
    den Hartogh, Jaap
    Ronckers, Cecile M.
    Tissing, Wim J. E.
    Loonen, Jacqueline J.
    Kremer, Leontien C. M.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (05)